Registered as of 10/16/2014 2020 Management Eric Weinberg 20/10 Perfect Vision Frieder Loesel, Managing Director 5AM Ventures Hannah H. Chang, Associate Abbott Laboratories John Capek, Executive Vice President, Medical Devices Abbott Medical Optics Leonard Borrmann, Divisional Vice President, R&D Darren Inouye, Commercial Director Refractive & Global Marketing Steve Jwanouskos, Associate Director, Regulatory Affairs Ken Kadziauskas, Associate Director & Marketing, Global Upstream Terry Koritz, Divisional Vice President, Commercial Refractive Catherine Mazzacco, Divisional Vice President, Commercial Operations Jane Rady, Divisional VP, Business Development MK Raheja, PhD, MBA, Global Head, Cataract R&D Cameron Rouns, Divisional Vice President, Global Strategic Marketing Murthy V. Simhambhatla, PhD, President David Tanzer, MD, Chief Medical Officer, DVP Medical Affairs Troy Wu, MD, Director, Business Development AbbVie Deb van Riet, Director Anita Riyat, Director, Corporate Strategy Samir Tari, Clinical Development Accutome Joelle Vega, President Ace Vision Group Dr. AnnMarie Hipsley, Founder Acucela Hien DeYoung, VP, Human Resources Karin Ludwig, MD, VP, Clinical Development AcuFocus Wellentina Greer, Director, Global Strategic Marketing Matt Larson, Commercial Director, Asia Pacific Jim Mazzo, Chairman & CEO Yari Mitchell, Director, Global Medical Education & Professional Relations Nick Tarantino, Chief Clinical & Regulatory Officer AECOS Trudy Larkins, Executive Director Aerie Pharmaceuticals Vicente Anido, CEO Mitchell Delong, Vice President, Chemistry Casey Kopczynski, Chief Scientific Officer Brian Levy, Chief Medical Officer Tom Mitro, President & Chief Operating Officer Richard Rubino, Chief Financial Officer Craig Skenes, Vice President, Business Development Aerpio Therapeutics Joseph H. Gardner, PhD, President & CEO AGTC Jeff Chulay, Vice President & CMO Dan Menichella, CBO Susan Washer, President & CEO Akorn Adrienne Graves, Former President & CEO Diane Houtman, Vice President, Profession Relations Al Consultants Avner Ingerman, Owner Alcon Judith Anderle, Global Product Director, Ocular Allergy Laurent Attias, Head, Global Commercial Strategy Sandipan Bagchi, Global Marketing Manager Sharon Bakalash, MD, PhD, Technical Lead Cataract David Chacko, Strategic Assistant to the Global Head of Alcon Arthur Ciociola, VP, Head of Global Regulatory Affairs Julie Collins, Director, Global Digital Marketing Fred Ellis, Head, Professional Affairs, US Pharmaceuticals Robert Fisher, Global Pharma Market Access Director Heather Floyd, PhD, Technical Lead Pharmaceutical Jeff George, Global Head Stephanie Grancharov, Head of Strategy Paul Hallen, Global Franchise Director-Vitreoretinal Jim Jogerst, Head, Business Development & Licensing Oliver Kersting, General Manager Gregory Kunst, Global Marketing Director, Retina Pharmaceuticals Franck Leveiller, PhD, VP, Head of Research & Development Vision Care Sabri Markabi, MD, CMO & Head R&D Anmol Mullins, Director, Global Market Access Jim Murphy, VP & GM, US Vision Care David Nieto, Chief Financial Officer Aaron Osborne, Head, GMA Pharma Franchise Scott Pennington, Head, R&D Alliances Dr. Cadmus Rich, Therapeutic Unit Head, IOLs Peter Richardson, CMO, Head Global Clinical & Regulatory Affairs Lukas Scheibler, PhD, VP, Ideation Center Gregg Stanhope, Director, Professional Affairs, US Pharmaceuticals Catherine Truitt, PhD, Technical Lead, VGR Robert Warner, Area President, United States & Canada Gergely Zimanyi, Director of Intellectual Property Alexion Pharmaceuticals Bill Lundberg, Vice President Alimera Sciences Rick Eiswirth, Chief Operating Officer & Chief Financial Officer C. Daniel Myers, President & Chief Executive Officer Alkeus Pharmaceuticals Leonide Saad, President & CEO Allegro Ophthalmics Hampar Karageozian, Co-Founder & CEO Vicken Karageozian, MD, Co-Founder & Chief Technology Officer Maria Leone, Business Development Consultant Allergan Yehia Hashad, VP, Global TA Head, Retina Gavin Herbert, Founder Patrick Johnson, Sr. Director, Business Development David Pyott, Chairman of the Board and CEO Brian Strem, Director, Business Development Ramin Valian, VP, Global Strategic Marketing, Eye Care Scott Whitcup, MD, Executive Vice President, Head of R&D & Chief Scientific Officer Allysta Pharmaceuticals Benson Fong, CBO Henry Hsu, CEO Alphaeon Robert Grant, CEO Jenna Mons, VP of Marketing Tony Sine, EVP Business Development Shareef Mahdavi, Chief Marketing Officer David Mordaunt, President Altacor Dr. Francesca Crawford, CEO Amakem Jack Elands, CEO Steve Pakola, Chief Medical Officer Kieran Rooney, VP, Business Development American Academy of Ophthalmology Jane Aguirre, Vice President, Global Alliances David W. Parke, MD, CEO Richard Zorab, Vice President, Clinical Education AmorChem John Clement, General Partner AnalyzeRx Sanjay Nayak, MD, PhD, Founder Apellis Pharmaceuticals Cedric Francois, CEO & President Federico Grossi, VP of Clinical Development David Watson, Executive VP of Development Apex Eye Robert Benza, MD, PI Ed Meier, MD, Director of Clinical Research Wendy Shoger, Director, Clinical Research Development Appletree CI Group AG Todd Galles Georg Mathis, Physician AppMedicine Robby Huang, CEO Aquesys Ron Bache, CEO ASCRS Don Bell, COO Eric Donnenfeld, MD, President David Karcher, Executive Director ASCRS Media Jeff Brownstein, Director of Sales Donald Long, Director of Media Cathy Stern, Production Manager Paul Zelin, Sales Representative ASSORT Noel Alpins, CEO Tom Barker, Director of Business Development & Strategic Alliance Doug Mastel, Product Specialist Avalanche Biotechnologies Linda Bain, Chief Financial Officer Samuel Barone, Chief Medical Officer Thomas W. Chalberg, PhD, Founder & CEO Hans Hull, SVO Business Operations Roman Rubio, Head of Translational Medicine Avedro Steve Blinn, Chief Commercial Officer David Muller, President & CEO Avelino Lab USA Scott Korney, COO Gene Lee, Chairman & CEO Weston Nichols, Director, Sales & Marketing Avella Leslie Yendro, VP, Business Development BAM Ophthalmology Consultants Beth Marsh, Principal Barclays Priya Karani, Director Jonathan Piazza, Director Bascom Palmer Eye Institute William Culbertson, Professor of Ophthalmology Philip Rosenfeld, MD, Professor of Ophthalmology Bausch + Lomb Andrew Chang, Vice President, Sales & Marketing Chuck Hess, Sr. Director of Marketing Raymond Larwood, Vice President Pharmaceutical Sales Sanjay Malieckal, Director, Marketing Quintus Ngumah, Director Clinical Development & Medical Strategy Calvin W. Roberts, MD, Executive Vice President & Chief Medical Officer Tracy Valorie, Vice President, Pharma Marketing Jon Williams, Director, Medical Affairs Bay Area Retina Roger Goldberg, Physician Bayer Healthcare Robert Lieberman, Associate Director, Global Market Research Bayer HealthCare Pharmaceuticals Tom Cordaro, Director, Strategy & Portfolio Management Ken Shaw, PhD, Sr. Director, BD&L & SM Baylor College of Medicine Jack Holladay, MD, Clinical Professor of Ophthalmology Beaver Visitec International Peter Hemingway, V.P. Strategy & Business Development BioComm Network Tad Heitmann, MBA, President Biolight Suzana Nahum Zilberberg, CEO BioQuest Roger Anderson, Partner Karen Bertrand, SVP, Biopharmaceutical Practice Leader Biosyntrx Ellen Troyer, CEO & Chief Research Officer Bio-Tissue Greg Sorenson, Business Development Rep Brar-Parekh Eye Associates Jai Parekh, MD, Managing Partner Bryn Mawr Communications David Cox, President & Group Publisher Steve Daily, News Director Alan Guralnick, Group Publisher David Levine, Vice President, Digital Division Bucci Laser Vision Institute Frank A. Bucci, President & Founder Bullseye Dropper Robert Behan, Director C.C.G. Partners Rick Coulon, Managing Partner California Pacific Medical Center Rona Silkiss, Chief, Div. of Ophthalmic Plastic, Reconstructive & Orbital Surgery Calpain Therapeutics Tim Lovell, CEO Cantor Fitzgerald Caroline Corner, Research Analyst Carle Michael Tsipursky, Physician Carl Zeiss Meditec Scott Meyer, Director, Strategic Business Development Vincent Patella, VP Professional Affairs Angelo Rago, SVP, Innovation & Operations Catalyst Biosciences Nassim Usman, CEO Cativer Bio Insights Stephen Judd, President Center for Excellence in Eye Care William Trattler, Director of Cornea Charles Retina Institute Steve Charles, Founder & CEO CheckedUp Richard Awdeh, Founder & CEO Mark Awdeh, CFO CHU Gabriel Montpied Dr. Hayette Rebika, Ophthalmologist Cincinnati Eye Institute Edward J. Holland, MD, Director, Cornea Services Citadel Erik Ostrowski, Analyst Clarion Healthcare Carol Kearney, Managing Director Clarity Medical Systems Barry J. Linder, MD, MS, CMO Rick Mangum, CFO Mark Mellin, CEO Clarus Ventures Emmett Cunningham, Jr., MD, PhD, MPH, Partner Nick Galakatos, Managing Director Michele Park, Principal Kurt Wheeler, Managing Director ClarVista Medical Glenn Sussman, VP, R&D Clearview Eye & Laser Medical Center Sandy Feldman, Medical Direcor ClinOps International Yordak Salermo, Clinical Consultant ClinReg Consulting Services Judy Gordon, President Lee Kramm, MD, Senior Regulatory Consultant Roger Meyer, MD, Consultant Cockrell Interests Bobby Hatcher, CEO Cole Eye Institue Neema G. Mayhugh, Director of Commercial Affairs Columbia University Medical Center Stephen Trokel, Vice Chair, Department of Ophthalmology Cornea/Retinal Diseases Image Analysis Reading Centers Beth Ann Benetz, Director Cressey & Company Steve Dildine, Vice President Cydan Aileen Healy, PhD, Vice President, Preclinical Developent D.O.R.C. International Pieter Karels, Strategic Product Development Director Willem Rosenquist, Strategic Product Management Director Dean McGee Eye Institute Gregory Skuta, President & CEO Department of Ophthalmology & Vision Sciences, UC Davis Christopher Murphy, Professor of Comparative Ophthalmology Destum Partners Matt Vanderberg, Managing Director, Partner DiagnosTear Nimrod Bin-Nun, Business Development DigiSight Technologies Doug Foster, CEO Draper Laboratory Brian Daniels, Program Manager Durrie Vision Daniel Durrie, MD, Founder & President EagleVision Murray Beard, President Eleven Biotherapeutics Abbie Celniker, CEO Michael Goldstein, MD, MBA, Vice President of Clinical Research Greg Perry, CFO Gary Sternberg, Executive Vice President of Corporate & Business Development Karen Tubridy, Chief Development Officer Encompass Pharmaceutical Services Thomas Rowe, President Encore Vision Bill Burns, President & CEO Envisia Therapeutics Neal Fowler, CEO Tomas Navratil, Vice President, Development Ash Nijhawan, Vice President, Business Development Ben Yerxa, CSO Escalon Medical Corp. Matt Carnevale, Chief Technology Officer Richard J. DePiano, Jr., CEO Barry Durante, President Enrique Pfeiffer, Chief Medical Officer Mark Wallace, COO Ethis Communications David Kellner, Exectuvie VP Lavon Kellner, Principal Director of Sales Luca Sergio, CEO Eton Park Capital Matt Reischl, Analyst EuroTimes Howard Larkin, Contributing Editor ExSight Capital James Murray, Partner Eye Associates of Washington D.C. Paul Gavaris, MD, President Eye Consultants of Texas Phillips Labor, Physician Eye Surgeons Associates Lisa Arbisser, Physician Eye Therapies Tony Moses, CEO EyeGate Pharma Stephen From, CEO Michael Manzo, VP of Engineering EyeKor Ron Danis, Managing Partner, CSO EyeNet Magazine Patty Ames, Executive Editor Peggy Denny, Senior Editor Chris McDonagh, Senior Editor Edna Shaw, Contributing Writer & Editor EyeQ Research Michael Lachman, Founder EyeSonix Don Schwartz, President EyeWorld Erin Boyle, Editor Julio Guerrero, Video Editor Lauren Lipuma, Staff Writer Ellen Stodola, Staff Writer FDA Kesia Alexander, Deputy Director Wiley A. Chambers, MD, Supervisory Medical Officer, Division of Transplant & Ophthalmology Products Malvina B. Eydelman, MD, Director, Division of Ophthalmic Device Evaluation Eva Rorer, Medical Officer Michelle Tarver, MD, Medical Officer Federal University of Sao Paulo Rubens Belfort, Head Professor Cristina Muccioli, MD, Professor of Ophthalmology FishmanVision Harvey Fishman, Medical Director Foresite Capital Stella Sarraf, Advisor ForSight Labs Eugene de Juan, MD, Founder & Vice Chairman Angela Macfarlane, President & CEO ForSight Vision4 Signe Erickson, VP, Development & Clinical ForSight VISION5 Charles Semba MD, Chief Medical Officer John Maroney, President & CEO Anne Rubin, Vice President, Marketing Foundation Fighting Blindness Tom Capetan, Business Development Consultant Patricia Zilliox, Chief Drug Development Officer GE Capital, Healthcare Financial Services David Anderson, Managing Director Genentech Bonaventure Agata, Disease Area Director – Ophthalmology Eugene An, GPM Warner Biddle, Vice President Lucentis Ophthalmology Sales & Marketing Ann Clark, Senior Medical Science Liaison Warren L. Creed, Clinical Specialist Atul Dandekar, Lifecycle Leader Jason Ehrlich, Group Medical Director Guillermo Elias, Senior Product Manager Carl Erickson, GPM Daniela Ferrara, Associate Medical Director Caroline Hartford, Senior Product Manager Daniel Kindelberger, Product Management Thomas Kochy, Director, Pipeline Strategy Phillip Lai, Senior Medical Director Georgia Li, Medical Director Chad McCrea, SPM Ajay Narasimha, Senior manager Lisa Tuomi, Senior Clinical Scientist Elisabeth Warren, Associate Director, Pipeline Strategy Thomas Zioncheck, Senior Director, Business Development Glaucoma Research Foundation Tom Brunner, President & CEO GlaxoSmithKline Claudine Bruck, VP & Head Ophthalmology R&D Rabia Ozden, MD, Head, Clinical Ophthalmology R&D Gobiquity Michael Brownell, CEO Google X Brian P. Otis, PhD, Founder, Smart Contact Lens Project GrayBug Michael O'Rourke, CEO Gray Communications Michele Gray, Principal Great Point Partners Aaron Hakim, Analyst Gurnet Point Capital Todd Holmes, Director Anne Rogove, Analyst Gustavson Development Michael Gustavson, President GZ Paul Management Services Helmut A. Krueger, Director Harvard Medical School Jonathan H. Talamo, MD, Associate Professor of Ophthalmology Healios Al Reaves, Director & Chief Development Officer HealthCare Royalty Partners Matt Reber, Managing Director HealthCor Partners Ed Ross, Analyst Healthios Capital Markets Greg Shearer, Managing Director Hospital das Clinicas Mauro Goldbaum, Ophthalmologist Hoya Corporation Akiteru Furukawa, General Manager Takashi Iizuka, Manager, Business Development i-Optics Jeroen Cammeraat, CEO Wayne Caulder, Cassini VP North America David Friess, Clinical Consultant Icare Finland Ari Kukkonen, R&D Director iCo Therapeutics Dr. Peter Hnik, Chief Medical Officer Susan Koppy, Corporate Business Development Executive Andrew Rae, CEO Icon Bioscience Hector Casab, VP Finance David Tierney, CEO Iconic Therapeutics Bill Greene, CEO Tanya Shnaydman, Director, Corporate Development & Operations IDDI Linda Danielson, COO Stan Wysocki, Senior Director, Business Development & Sales Operations Illinois Eye & Ear Infirmary Ahmad A. Aref, MD, Assistant Professor of Ophthalmology Yannek Leiderman, Vitreoretinal Surgeon Illinois Institute of Technology Jennifer Kang-Mieler, Associate Professor of Biomedical Engineering Imex Clinic SL Jose Maria Gimeno Reiz, President & CEO Implandata Ophthalmic Products GmbH Max G. Ostermeier, CEO & President Imprimis Pharmaceuticals Bindu Manne, Regional Business Director Indiana University Alon Harris, MS, PhD, FARVO, Director, Clinical Research Infinite Vision Optics Carsten Laue, CEO Infinov Benoit Collet, President Ingeneus Richard Walmsley, CEO InnFocus Russ Trenary, President & CEO Guy Van de Weyer, Director Operations Europe, Middle East, Africa Integrity Digital Solutions Chris Moore, CEO InterWest Partners Charline Gauthier, Executive-in-Residence Gilbert H. Kliman, MD, Managing Director Reza Zadno, Venture Partner Intralase Ronald Kurtz, CEO IOPtima Ronen Castro, CEO Iris Advanced Eye Centre Raman Bedi, MD, Physician Iris Pharma Pierre-Paul Elena, CEO Yann Quentric, Head of Business Development & Marketing ISOPT Dr. Sara Krupsky, Chairperson iSTAR Medical Pierre Geens Michel Vanbrabant Ivantis Dave Van Meter, CEO J.P. Morgan Michael Gaito, Managing Director & Head of West Coast Life Sciences Jeffrey Hoffman, Managing Director, Head West Coast Healthcare Investment Banking Janssen Pharmaceuticals Susan Orr, Global Medical Affairs Leader, Ophthalmology Janssen Research & Development Rob Willenbucher, Head Cell Therapy & Janssen Incubators Japan Focus Makoto Wakayama, Assistant Manager Jefferies Biren Amin, Managing Director JFC Sales Plan Masataka Fujikawa, Chief Tsugitomo Takimoto, Chairman John Guckes & Associates John Guckes, President Johnson & Johnson Ellie Chabi, MD, Physician Hassan Chaouk, X Louis Dias, Director Christine Knoblauch, Vice President, WW Business Development Ashley McEvoy, Company Group Chairman Brian Schwam, Chief Medical Officer Art Shedden, MD, MBA, Senior Director, Global Medical Affairs Peter Shen, VP WW R&D JP Morgan Jeffrey Hoffman, Managing Dir. & Head West Coast Healthcare Investment Banking JRM Holdings Jose Roberto Alegre, CEO Jump Capital Garrett Vygantas, MD, Partner JunoPacific Kern Bhugra, President Kaiser Associates Dan O’Neill, Senior Vice President Bob Serrano, Vice President Kala Pharmaceuticals Kim Brazzell, Chief Medical Officer Charlie McDermott, Chief Business Officer Kato Pharmaceuticals Terry McGovern, CEO Kepler Schalon Newton, Principal Kraff Eye Institute Colman R. Kraff, MD, Director of Refractive Services Laboratories Thea Francou Colin, Corporate Business Development Manager Pascale Pouliquen, Corporate Medical Director Laboratories SALVAT Hugo Peris, Board Member LacriPen Jay M. Eastman, Professor Chris D. Geddes, Biochemical Engineer LayerBio Ken Mandell, CEO Leerink Partners Tony Gibney, Managing Director Joseph Schwartz, Managing Director Leica Microsystems AG Heinrich Dreyer, Vice President, Medical Division LensGen Michael Colaco, Board Member Shivbir Grewal, Board Member Michael Landreville, Chief Operating Office Ram Rao, CEO Lensar Nick Curtis, CEO Pete Mariani, CFO Lenticular Research Group George McArdle, OD, Optometrist Leonidas A Johnson, O.D., APC Leonidas Johnson, Optometrist Lifecore Biomedical Kipling Thacker, PhD, Chief Scientific Officer & VP Linden Capital Partners Tony Davis, Managing Partner Eric Larson, Managing Partner Link Consulting Marsha Link, PhD, Principal London Eye Hospital Pharma Rob Hill, CEO Longitude Capital Juliet Bakker, Managing Director Andrew ElBardissi, Vice President Lumenis Ezer Bar-Aviv, Business Development Surgical Business Unit Assaf Gelstein, Director, Global Products Liat Hadad, Director, Product Marketing Flavio Longato Itay Mayer, Director, Product Marketing Adi Rizansky Nir, Global Product Marketing Manager, Vision Business Unit Lumoptik Eye Thomas Janicki, President Lutronic Haelyung Hwang, President Jongmin Kim, CTO M&S Technologies Joseph Marino, President & CEO Managed Care First Report & P&T Magazine Peter Sonnenreich, Senior Editor Mark Packer MD Consulting Mark Packer, President Market Scope Bill Freeman Massachusetts Eye & Ear Bonnie M. Brodowski, MBA, Program & Business Development Manager Reza Dana, MD, MPH, MSc, Claes H. Dohlman Professor of Ophthalmology Ojas Mehta, Director, IP & Commercial Ventures Jonathan Talamo, Site Director Mati Therapeutics Bob Butchofsky, CEO Chris Muller, CCO Mayo Clinic Arthur Sit, Associate Professor MC2 Biotek Frederic Gomez, Advisor, Business Development Jesper J. Lange, President Morten Prostegaard, VP Operations McMaster University Zuhal Butuner, Associate Professor medeuronet Kristine Morrill, Managing Director Medical Device Daily Larry Haimovitch, Reporter Medicem Eugen Chicevic, Managing Director Giacomo Nizi Vladimir Stoy, President Mediphacos Ophthalmic Professionals Gustavo Couri, Commercial Director Marcelo Soares, President Mercy Eye Clinic Jack Bussa, MD, Physician MicroOptx Medical Chris Pulling, CEO Mid Atlantic Bio Angels Eric D. Kanter, MD, Partner Mid Atlantic Retina-Wills Eye Institute Carl Regillo, MD, Professor of Ophthalmology Mimetogen Pharmaceuticals Garth Cumberlidge, President & CEO Francois Mongrain, CFO Minnesota Eye Consultants Richard Lindstrom, MD, Founder & Attending Surgeon Mobius Therapeutics Jim Brocato, Director, National Accounts Ed Timm, President & CEO Monash Vision Group Jeanette Pritchard, General Manager Moorfields Pharmaceuticals Rob Wallace, Business Development Director MT Coroneo Pty Ltd Minas Coroneo, Professor Mynosys Cellular Devices John N. Hendrick, President & CEO Mystic Pharmaceuticals Timothy Sullivan, President & CEO Nanovision Group Anton Archipov, President & CEO National Eye Institute, NIH Matthew J. McMahon, PhD, Director, Office of Translation Research Navigant Derakhshan Behrad, Physician Jeff Evanson, Healthcare Consultant Todd Waldman, Director NDC Edwin Keates, Consultant Neurotech Quinton Oswald, CEO Rhett Schiffman, VP & CMO Rich Small, CFO NeuroVision Steven Verdooner, CEO New World Medical Suhail Abdullah, Director, Research & Development Bilal Khan, Vice President & Chief Operating Officer NextGen Healthcare Tera Roy, Specialty Director, Ophthalmology Nicox Mike Bergamini, EVP & Chief Scientific Officer Gavin Spencer, EVP, Corporate Development NIDEK Tokio Ueno, Senior Manager Nightstarx Aniz Girach, CMO nJoy Vision Dawn Holsted, President & CEO North Shore LIJ Health System Ira Udell, Physician, Chairman NotalVision Yair Alster, CMO Barak Azmon, CEO Scott Jones, President Novaliq GmbH Gerald Cagle, MD, Physician Bernhard Guenther, CEO Frank Loescher, Director, Business Development Tony Pettigrew, Director, New Products Dieter Scherer, CSO Hartmut Voss, Executive Advisor Novartis Pharma Ronny Hashmonay Dirk Sauer, Global Head, Development Franchise Ophthalmics Mark Wuttke, Global Brand Manager, New Products, Medical Retina Edward Wright, BD&L Manager Novozymes Biopharma Michael Foldager, Global Marketing Manager NSBRI Dorit Donoviel, PhD, Deputy Chief Scientist and Industry Forum Lead Nudrop David Cohen, Commercial Direcor Ocugen Charlie Kang, CEO Ocular Instruments Scott Corning, VP, Sales & Marketing Phil Erickson, President Raymond Graham, Director of Engineering & Product Development Amar Sawhney, PhD, President & CEO Brad Smith, CFO Ocularis Pharma Alan R. Meyer, CEO Oculeve Michael Ackermann, President & CEO Daniel Hamilton, Vice President, Clinical Affairs OCULUS Surgical Ron Gilliland, President and CEO Bob Zatarain, V.P. Business Development OD-OS Ulrich Kinzel, Consultant Dr. Winfried Teiwes, CEO Oftalmedica Benedetto Sgroi, CEO OHR Pharmaceutical Irach Taraporewala, CEO & President OneFocus Vision Steve Waite ONL Therapeutics John Freshley, CEO David Zacks MD, PhD, Co-Founder and CSO Oligasis Victor Perlroth, Founder & CEO Opthalmiatreion Athens Eye Hospital Iordanis Chatziangeldis, Ophthalmologist Ophthalmology Times Mark Dlugoss, Editor-in-Chief Ophthotech Mike Atieh Richard Beckman, Senior Vice President Hans Christinger, VP, Business Development & Alliance Management Kathy Galante, Vice President, Investor Relations David R. Guyer, MD, CEO Jeffrey Nau, VP, Clinical & Medical Affairs Samir Patel, President Michael Rafa, VP & Chief Patent Counsel Keith Westby, Sr. Vice President, Program Management & Business Operations Barbara Wood, SVP, General Counsel & Corporate Secretary Oppenheimer & Co Yigal Nochomovitz, Analyst, Equity Research OptiMedica Mark Forchette, Former CEO Ora Stuart Abelson, President & CEO Ryan Bouchard, Director, Medical Devices Matthew Chapin, Sr. VP, Corporate Development Phil Gioia, Corporate Development Mashfiq Haque, Director, Business Development Eliot Lazar, Physician Hiro Matsuda, General Manager Joshua Moriarty, Director, Medical Communications George Ousler, Vice President, Dry Eye MaryJane Rafii, Director, Business Development Van Sandwick, Corporate Development Associate Aron Shapiro, Vice President Oraya Therapeutics Jim Taylor, President & CEO Pacific Eye & Laser Institute Rochelle Rongavilla, Research Supervisor Jimmy Tan, Managing Director Harvey Uy, Medical Director Palo Alto Investors John Doux, Physician Pamel Vision & Laser Group Elizabeth Jett, Clinical Research Coordinator Gregory Pamel, Owner Panoptes Franz Obermayr, CEO PanOptica David P. Bingaman PhD, DVM, ACVO, Sr. Director & Head, Retina Development Paul Chaney, President & CEO Marty Wax, MD, Chief Medical Officer & EVP, R&D Paragon BioTeck Patrick Witham, CEO Parexel International Patricia Cominsky, Senior Director, Business Development Parion Sciences Jose Boyer, VP Research & Ophthalmology Development Pascale Communications Georgette Pascale, President & CEO Pasteur Ophthalmic Clinic Jaime Zacharias, Physician Patterson Thuente IP Paul Onderick, Intellectual Property Attorney & Eye Doctor PentaVision Rich Kirkner, Executive Editor Andrew Mathis, Managing Editor of Retinal Physician Perceptive Life Sciences Fund Hossein Ekrami, Senior Analyst Pharmacos Jim Currie, Principal PharmaQuest Associates Lisa Grillone, President Phillips Medisize Vince Hull, Director, Product Development Joe Slade, Program Manager Piper Jaffray & Co. J.P. Peltier, Managing Director and Global Group Head of Healthcare Investment Banking PowerVision Barry Cheskin, President, CEO & Co-Founder Matt Frinzi, Chief Business Officer & Founder PRECEYES Gerrit Naus, CEO Atul Sinha Presbia Vlad Feingold, Executive VP & CTO Zohar Loshitzer, President Promedica Shannon Stoddard, President pSivida Paul Ashton, CEO Quantel Medical Peter Falzon, Business Development Rainbow Medical Roy Katz, VP Business Development Refocus Group Mark Cox, Executive Vice President Mike Judy, CEO Stephon C. Payseur, Director Strategic Communications Regeneron Keith Baker, Associate Director of Medical Affairs, Ophthalmology Abby Cahn, Sr. Manager Strategic Accounts Planning Nouhad Husseini, Senior Director Husain Kazmi, Director Clinical Sciences, Ophthalmology Neil Levine, Sr. Director of Marketing John Magliocchetti, Sr. Director Ophthalmology, New Products Marketing Carl Romano, Executive Director, Ophthalmology Namrata Saroj, Sr. Medical Director Medical Affairs, Ophthalmology Reichert Technologies Chris Thatcher, Division Vice President & Business Unit Manager Replenish Ted Danse, CEO Retina Associates Ben Z. Cohen, Physician Retina Consultants Charles Vygantas, MD, Physician Retina Consultants of Delmarva Jeffrey Benner Retina Health Center Alexander Eaton, MD, Physician Retina-Vitreous Associates David Boyer, MD Steven Cohen, MD, Partner Firas M. Rahhal, MD, Partner RetinaNet Mark Nelson, MD, MBA, CEO RetroSense Therapeutics Sean Ainsworth, CEO ReVision Optics Luis Vargas, MD, VP, Medical Affairs & Medical Director Roche Innovation Center New York Patrick Schleck, Director, Global Business Development Rocky Mountain Ophthalmology Kevin Cuevas, Cornea Specialist Rohto pharmaceutical Takahiro Kurose, Business development Ron Neumann Ron Neumann, Physician Rowen Laser Vision Center Sheri Rowen, Medical Director Rutgers-New Jersey Medical School Marco Zarbin, MD, Professor & Chair, Institute of Ophthalmology & Visual Science RxGen Christopher Stanley, VP & CBO RXi Pharmaceuticals Corporation Geert Cauwenbergh, President & CEO SalutarisMD Maryline Boulay, Corporate Development & EU Affairs Laurence Marsteller, MD, CEO Sandbox Strategic Amy Jacobs, Vice President Dawn Thompson, President & Co-Founder Santen Yusuf Ali, VP, R & D Masato Asai, Head Robert Bauer, Manager Harumi Kawabata, Licensing Coordinator Jerome Martinez, President Sri Mudumba, Sr. Director, Pharmaceutical Dev. Takashi Noaki, Scientific Affairs & Global Business Development Ram Palanki, Vice President Ken Shimokawa, Senior Manager Tatsuyuki Yamane, Senior Manager, Global BD Scheie Eye Institute/University of Pennsylvania Alexander Brucker, MD, Professor of Ophthalmology Second Sight Medical Products Robert Greenberg, MD, PhD, President & CEO See Clearly Vision Group Dr. Rajesh Rajpal, Physician Sensimed AG David Bailey, CEO Sentinel Diagnostic Imaging David Meadows, CEO Sharklet Technologies Mark Spiecker, CEO Shifamed Mariam Maghribi, Chief Business Officer Shire Robert Dempsey, Vice President & Business Unit Head Kathryn Gregory, Sr. Director Business Development Reza Haque, MD, Vice President, Ophthalmology Scott Hunter, US Marketing Lead – Ophthalmology Jeanette Ilett, Business Unit Partnership Keyur Patel, MD, Medical Science Liaison Lead Gregory Robinson, Senior Director, Scientific Licensing Monica Roy, Director, Clinical Development, Ophthalmology SightLife Monty Montoya, President & CEO SightLine Partners Buzz Benson, Managing Director Joe Biller, Managing Director Sightpath Medical Joel Gaslin, VP of Sales & Marketing Signet Healthcare Partners Joyce Erony, Managing Director Silicon Valley Bank Hans Hinrichs, Managing Director Brett Maver, Director Singapore Eye Research Institute Dr. Danny Belkin, Business Development Director Xiaoqin Fang, Technology Development Manager Slack Samantha Costa, Online Managing Editor David Mullin, Editor-in-Chief Joan-Marie Stiglich, Chief Content Officer South Florida Vision Associates Jennifer Loh, Physician Square 1 Partners Lauren Kanner, Co-Founder & Strategist Stanford University Mark Blumenkranz, MD, Professor & Chairman, Department of Ophthalmology Suzann Pershing, MD, Chief, Ophthalmology & VA Palo Alto Health Care System Kuldev Singh, MD, Professor Stein Eye Institute, UCLA Steven Schwartz, Retina Division Chief Stem Cells Joel Naor, VP, Clinical Development, Ophthalmology Strategic Intelligence Babak Nemati, President Strategic Pharma Solutions Courtney Kaprelian, COO Stroma Medical Corporation Douglas Daniels, CEO Summit Eye Associates William Gates, Physician Surgilum/Surgical Eye Care Alan Brown, MD, President SurgiVision Consultants Guy M. Kezirian, MD, President SV Life Sciences Advisers Jim Watchtman, Venture Partner SVB Capital Jonathan Norris, Managing Director SVLSA Steven Straus, None Taejoon Pharm Joon Youb, PhD TearScience Nicole Wicker, CFO TearScience Tim Willis, President & CEO Technolas Kristian Hohla, CEO Teva Pharmaceuticals Jeanne Andronowitz, Global Marketing Director Christine Foster, VP, Search & Evaluation Diane Harvey, Senior Director, Search & Evaluation Texas Retina Associates Karl Csaky, MD, PhD, Partner The Center for Eye Care & Optical James F. Collins, MD, Founder & Medical Director The Foundry Hanson Gifford, Partner The Fundingsland Group Bradley Fundingsland, President Erin Schalhorn, Vice President The Glaucoma Foundation Scott Christensen, President & CEO The Magnum Group Randy McDonald, Managing Director & President The New York Eye & Ear Infirmary Robert Ritch, MD, Surgeon Director & Chief, Glaucoma Services The Retina Clinic Kartik Patel, Physician Theravance Biopharma Jeff Finer, VP Research, Molecular & Cellular Biology Thomas Resource Group Terry Thoma ThromboGenics Laurens Bouckaert, Global Marketing Director Jean Feyen, PhD, Head Preclinical Research Pascal Merchiers, Head Project Development David Pearson, Global Head, Corporate Development Topcon Michael Sinai, Senior Manager, Product Planning Transcend Medical Ginger Clasby, VP, Clinical & Regulatory Affairs Michael Schaller, R&D Manger Brian Walsh, CEO Translatum Medicus inc (TMi) Shelley Boyd, President & CSO Trial Runners Patrick Healy, CEO TrueVision Systems Mark Maire, Vice President of Sales Burton Tripathi, CTO & EVP of Product Development & Operations Tufts Medical Center Daniela Ferrara, MD, PhD, Assistant Professor of Ophthalmology UCLA School of Medicine David Sarraf, MD, Clinical Professor, Ophthalmology UCSF Daniel Schwartz, MD David Sretavan, Professor United Scientific Associates Dr. Hakam Ghabra University of California San Diego Robert Weinreb, MD, Chairman & Distinguished Professor University of California SF Stephen McLeod, MD, Professor & Chairman University of California, Irvine Roger Steinert, MD, Professor & Chair University of Florida William Hauswirth, PhD, Rybaczki-Bullard Professor of Ophthalmology Nick Muzyczka, Dept of Molecular Genetics & Microbiology University of Illinois at Chicago Dimitri Azar, Dean of College of Medicine William Mieler, MD, Professor & Vice-Chairman Suseelan Pookote, Senior Technology Manager University of Rochester Prof. Wayne H. Knox, Professor Optics & Visual Science Scott MacRae, MD, Director of Refractive Surgery, Professor of Visual Science University of Southern California Mark Humayun, MD, PhD, Professor University of Sydney Michael Lawless, Clinical Associate Professor University of Toronto Joseph Ma, Assistant Professor Unilife Gautam Shetty, Director & General Manager USC Rohit Varma, Professor & Chair UW School of Medicine & Public Health Paul Kaufman, MD, Professor & Chair Valeant - Bausch & Lomb Division Baldo Scassellati Sforzolini, VP, Development Eye Care Johnson Varughese, Executive Director, Clinical Development Valley Retina Institute Dr. Victor Gonzalez, Physician & Founder Vance Thompson Vision Vance Thompson, MD, Director of Refractive Surgery VCU, Richmond/INOVA Fairfax Hospital Michael Ross, MD, Professor Venture Investors Jim Adox, Managing Director Versant Ventures Andy Corley, Venture Partner William J. Link, PhD, Managing Director Charles Warden, Managing Director Vestrum Health Nadeem Ahmad, Director of Operations Nicholas Anderson, Co-Founder Tom Brogan, CEO John Pollack, Co-Founder David Williams, Co-Founder Visometrics Jan Bonel, CEO VisionCare Ophthalmic Technologies Allen Hill, CEO Vision Medicines Brinda Balakrishnan, MD, PhD, Senior Director Product Development & Strategy Jonae Barnes, SVP, Investor Relations & Corporate Communications Robert Kim, Vice President Research & Development Chris Varma, CEO VisuMedics George Marcellino, Vice President Vital Art & Science George Mavro, CMO Vitreous Retina Macula Consultants of New York Bailey Freund, MD Vittamed Corporation Remis Bistras, CEO VRMNJ Vatsal Doshi, Physician WaveTec Vision Systems Craig Bender, Chief Operating Officer Michael Breen, VP, Clinical Scott Cooper, CFO Thomas Frinzi, CEO Whipps Cross University Hospital Marwan Ghabra Williams Eye Surgery Johnny Williams, MD, Physician Wills Eye Institute Julia Haller, MD, Ophthalmologist-in-Chief Wilmer Eye Institute Howard Ying, Associate Professor of Ophthalmology WilmerHale Brian Johnson, Partner Windham Ventures Cynthia Yee, Principal Woodhams Eye Clinic George Waring, III, Physician Wordsmith Consulting Jan Beiting Xcovery Vision Teri Ardleigh Swift, Co-Founder & VP Business Development XOMA Oscar Cuzzani, VP, Clinical Science Tom Klein, VP & Chief Commercial Officer Brion Raymond, Sr. Director, Marketing Paul Rubin, Chief Medical Officer John Varian, CEO Ziemer Ophthalmic Systems AG Sandro Palumbo, VP Marketing Independent Keith Barton, MD Scott Beardsley Andre Curi William De La Pena, MD Donald Fishbein, Healthcare Executive Masayuki Kobayashi Dr. Bruce M. Lennox, Physician Julie Lyons Marion Munk Michael Nissen, MD, Physician Andrew Schachat Susan Schneider Arunan Sivalingam, MD Todd Smith
© Copyright 2024 Paperzz
